Two New Biomarkers May Help Predict Colorectal Cancer Patients’ Response to Therapy
Researchers identified two biomarkers that predict whether patients with colorectal carcinoma will respond well to treatment with Erbitux (cetuximab) or the chemotherapy agent 5FU, according to a new study. These ... Read more